[Multiple pulmonary emboli complicating infective endocarditis in a child with congenital heart disease].
Pulmonary embolism in children is a rare condition, associated with high mortality. Clinical presentation is nonspecific. Pulmonary embolism may present initially similar to bacterial endocarditis of the right heart, septic thrombophlebitis, or osteomyelitis. We report the case of a 6-year-old girl who had dyspnea over the four months before consultation, complicated three months later by hemoptysis. She was diagnosed with subacute bacterial endocarditis secondary to group D Streptococcus, developed upon a ventricular septal defect. Two weeks later, the child had sudden chest pain and tachypnea. Lung scintigraphy showed multiple pulmonary embolisms. The therapeutic approach was to continue antibiotics without anticoagulant treatment. The outcome was favorable with apyrexia and stabilization on the respiratory level. Pulmonary embolism is a rare disease in children with an incidence of 3.7%. Classically, it presents with fever, hemoptysis, and nonspecific infiltrates on chest X-ray. These signs were noted in our patient, although the infiltrates on the chest X-ray were hidden by the pulmonary edema associated with heart failure. The persistence of these left basal opacities after antidiuretic treatment suggested an infectious origin. Subsequently, lung scintigraphy showed that it was a pulmonary infarct. The therapy of septic pulmonary embolism is the same as that for infective endocarditis. Antibiotic treatment alone was maintained without anticoagulants because of the high risk of bleeding at the seat of the pulmonary embolism and the insubstantial significant benefit of this therapy. Pulmonary embolism in children is a rare disease, but its incidence is underestimated. Better knowledge on its actual impact and etiologies in children is necessary. Multicenter studies are needed to establish recommendations.
Service de pédiatrie A, faculté de médecine et de pharmacie de Marrakech, université Caddy Ayyad, hôpital Mère-Enfant, CHU Mohamed VI, Marrakech, Maroc. Electronic address: s.ajdakar@gmail.com.
S
S
Ajdakar
Service de pédiatrie A, faculté de médecine et de pharmacie de Marrakech, université Caddy Ayyad, hôpital Mère-Enfant, CHU Mohamed VI, Marrakech, Maroc.
M
M
Elbouderkaoui
Service de pédiatrie A, faculté de médecine et de pharmacie de Marrakech, université Caddy Ayyad, hôpital Mère-Enfant, CHU Mohamed VI, Marrakech, Maroc.
N
N
Rada
Service de pédiatrie A, faculté de médecine et de pharmacie de Marrakech, université Caddy Ayyad, hôpital Mère-Enfant, CHU Mohamed VI, Marrakech, Maroc.
G
G
Drais
Service de pédiatrie A, faculté de médecine et de pharmacie de Marrakech, université Caddy Ayyad, hôpital Mère-Enfant, CHU Mohamed VI, Marrakech, Maroc.
M
M
Bouskraoui
D002648:Child; D004697:Endocarditis, Bacterial / Q000150:complications*; D013293:Enterococcus faecalis; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000150:complications*; D006330:Heart Defects, Congenital / Q000150:complications*; D006801:Humans; D011655:Pulmonary Embolism / Q000209:etiology* / Q000473:pathology